Literature DB >> 7806147

Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation.

P W Angus1, S A Locarnini, G W McCaughan, R M Jones, J S McMillan, D S Bowden.   

Abstract

The factors that predispose patients undergoing liver transplantation for hepatitis B virus (HBV) disease to severe recurrence of infection are unclear. In this study we examined the effect of pretransplantation infection with HBV and precore variant strains of HBV on posttransplantation outcome and allograft histology in 24 patients who survived more than 3 months after liver transplantation. Based on pretransplantation serum HBV DNA status as detected by the polymerase chain reaction (PCR) and direct sequencing, the 24 patients could be assigned to three groups. In group 1 there were 4 patients HBV DNA-negative before transplantation and none of these patients suffered recurrence of infection posttransplantation. In group 2, of 10 patients with pretransplantation infection with wild-type virus, 7 became reinfected, and 1 of these developed HBV-related graft failure. In group 3, 9 of 10 patients infected with precore mutant HBV strains became reinfected. However, in contrast to the patients in group 2, 7 patients in group 3 developed HBV-related graft loss, and 5 of these patients had fibrosing cholestatic hepatitis (FCH). These results indicate that infection with precore mutant strains of HBV predisposes a patient to early graft loss following transplantation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7806147

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  8 in total

1.  Prevention of post liver transplant HBV recurrence.

Authors:  Geoffrey W McCaughan
Journal:  Hepatol Int       Date:  2011-08-10       Impact factor: 6.047

2.  Hepatitis B virus infection and liver transplantation.

Authors:  N A Terrault; T L Wright
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

Review 3.  Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome.

Authors:  Tahereh Ghaziani; Hossein Sendi; Saeid Shahraz; Philippe Zamor; Herbert L Bonkovsky
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

4.  Reactivation of viral replication after liver resection in patients infected with hepatitis B virus.

Authors:  S Kubo; S Nishiguchi; H Hamba; K Hirohashi; H Tanaka; T Shuto; H Kinoshita; T Kuroki
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

5.  Strong association between genotype F and hepatitis B virus (HBV) e antigen-negative variants among HBV-infected argentinean blood donors.

Authors:  Paulo H C França; Jorge E González; M Silvina Munné; Larissa H Brandão; Vera S Gouvea; Erwin Sablon; Bart O M Vanderborght
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

6.  Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis.

Authors:  Shu-Yuan Xiao; Liang Lu; Hanlin L Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  A mechanism to explain the selection of the hepatitis e antigen-negative mutant during chronic hepatitis B virus infection.

Authors:  Lars Frelin; Therese Wahlström; Amy E Tucker; Joyce Jones; Janice Hughes; Byung O Lee; Jean-Noel Billaud; Cory Peters; David Whitacre; Darrell Peterson; David R Milich
Journal:  J Virol       Date:  2008-11-12       Impact factor: 5.103

8.  Severe de novo Hepatitis B Recovered from Late-Onset Liver Insufficiency with Prolonged Ascites and Hypoalbuminemia due to Hepatitis B Virus Genotype Bj with Precore Mutation.

Authors:  Akira Sato; Toshiya Ishii; Fumiaki Sano; Takayuki Yamada; Hideaki Takahashi; Nobuyuki Matsumoto
Journal:  Case Rep Gastroenterol       Date:  2016-10-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.